News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,366 Results
Type
Article (14685)
Company Profile (308)
Press Release (270373)
Section
Business (85584)
Career Advice (197)
Deals (14361)
Drug Delivery (37)
Drug Development (50676)
Employer Resources (32)
FDA (5930)
Job Trends (5664)
News (152491)
Policy (10593)
Tag
Academia (996)
Alliances (23738)
Alzheimer's disease (786)
Antibody-drug conjugate (ADC) (65)
Approvals (5917)
Artificial intelligence (92)
Bankruptcy (105)
Best Places to Work (4956)
Biotechnology (251)
Breast cancer (126)
Cancer (1027)
Cardiovascular disease (84)
Career advice (173)
CAR-T (82)
Cell therapy (242)
Clinical research (40589)
Collaboration (398)
Compensation (152)
COVID-19 (1036)
C-suite (102)
Cystic fibrosis (73)
Data (1054)
Diabetes (96)
Diagnostics (1372)
Earnings (30265)
Events (49398)
Executive appointments (317)
FDA (6366)
Funding (374)
Gene editing (70)
Gene therapy (180)
GLP-1 (328)
Government (1136)
Healthcare (7240)
Infectious disease (1078)
Inflammatory bowel disease (100)
IPO (7517)
Job creations (991)
Job search strategy (165)
Layoffs (201)
Legal (1526)
Lung cancer (151)
Manufacturing (95)
Medical device (2941)
Medtech (2943)
Mergers & acquisitions (7036)
Metabolic disorders (288)
Neuroscience (1067)
NextGen: Class of 2025 (2346)
Non-profit (987)
Northern California (1222)
Obesity (155)
Opinion (98)
Parkinson's disease (82)
Patents (69)
People (27342)
Phase I (14293)
Phase II (18848)
Phase III (11973)
Pipeline (455)
Postmarket research (867)
Preclinical (6013)
Radiopharmaceuticals (207)
Rare diseases (223)
Real estate (1663)
Regulatory (8720)
Research institute (1025)
Series A (73)
Southern California (1094)
Startups (2138)
United States (9769)
Vaccines (179)
Weight loss (91)
Date
Today (77)
Last 7 days (233)
Last 30 days (1203)
Last 365 days (20925)
2025 (1076)
2024 (21091)
2023 (23055)
2022 (28782)
2021 (30874)
2020 (26385)
2019 (18685)
2018 (13502)
2017 (14547)
2016 (12692)
2015 (15282)
2014 (11112)
2013 (8124)
2012 (8245)
2011 (8394)
2010 (8035)
Location
Africa (167)
Asia (18396)
Australia (3051)
California (2782)
Canada (878)
China (259)
Colorado (103)
Connecticut (119)
Delaware (67)
Europe (39403)
Florida (312)
Georgia (82)
Illinois (180)
Indiana (76)
Maryland (369)
Massachusetts (2208)
Minnesota (123)
New Jersey (694)
New York (777)
North Carolina (451)
Northern California (1222)
Ohio (89)
Pennsylvania (537)
South America (246)
Southern California (1094)
Texas (311)
Washington State (266)
285,366 Results for "enterprise therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QuantHealth Expands Its Leadership Team, Primes its SaaS Platform for Enterprise-Grade Pharmaceutical Partnerships
January 13, 2025
·
4 min read
Drug Development
Enterprise Therapeutics Publishes Preclinical Profile of ETD001, a Novel Inhaled ENaC Blocker
Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, announced the publication of a peer reviewed study in the Journal of Cystic Fibrosis.
June 12, 2024
·
2 min read
Press Releases
Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001, a Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
November 19, 2024
·
3 min read
Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Enterprise Therapeutics Ltd announced that it has closed a £26 million Series B follow-on financing round, led by Panakes Partners.
January 30, 2024
·
2 min read
Press Releases
Enterprise Therapeutics Granted ‘Rare Pediatric Disease Designation’ in the US for Novel Cystic Fibrosis Investigational Therapy ETD001
September 26, 2024
·
2 min read
Press Releases
First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to Revolutionize Cancer Treatment
January 13, 2025
·
4 min read
Press Releases
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
November 5, 2024
·
3 min read
BioMidwest
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
Ludwig Enterprises, Inc is pleased to announce that its subsidiary Exousia AI is funding a preclinical study on Glioblastoma, an incurable brain cancer.
March 27, 2024
·
3 min read
Business
Humana Appoints President of Enterprise Growth
Leading health insurer and health care services company Humana Inc. announced that it has named David Dintenfass as President of Enterprise Growth.
January 25, 2024
·
3 min read
Business
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
Eli Lilly and Company announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly’s Executive Committee, will retire after 27 years of service with the company, effective Dec. 31, 2024.
May 15, 2024
·
3 min read
1 of 28,537
Next
